Production (Stage)
Fresenius Medical Care AG
FMS
$29.02
$0.48711.71%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 106.59% | -64.75% | 155.09% | 31.76% | -16.83% |
| Total Depreciation and Amortization | -4.35% | -2.90% | -4.28% | -32.56% | -10.35% |
| Total Amortization of Deferred Charges | -- | -7.63% | -- | -- | -- |
| Total Other Non-Cash Items | -84.79% | 2,282.58% | -198.97% | -401.05% | 307.35% |
| Change in Net Operating Assets | 11.31% | 75.94% | 64.40% | -74.95% | -26.16% |
| Cash from Operations | 23.98% | 14.52% | 30.91% | -56.56% | -9.78% |
| Capital Expenditure | -5.52% | 4.78% | -22.10% | -1.43% | 4.63% |
| Sale of Property, Plant, and Equipment | -23.76% | -34.06% | -240.55% | 9,800.44% | 172.29% |
| Cash Acquisitions | -777.29% | 1.16% | -88.42% | 34.52% | 121.52% |
| Divestitures | -53.80% | -13.79% | 344.57% | 3,394.84% | 227.50% |
| Other Investing Activities | 0.83% | -43.15% | -263.14% | 9.38% | 167.41% |
| Cash from Investing | -53.48% | -22.30% | -47.01% | 339.19% | 57.61% |
| Total Debt Issued | -64.25% | 27.55% | 103.29% | -119.61% | -13.39% |
| Total Debt Repaid | 65.38% | -32.52% | -118.13% | 47.33% | -106.65% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -5.06% | -- |
| Other Financing Activities | -15.36% | -93.96% | -24.84% | 52.45% | 36.91% |
| Cash from Financing | 53.55% | -28.17% | -16.87% | -17.86% | -14,659.08% |
| Foreign Exchange rate Adjustments | -381.77% | 309.16% | -174.59% | 77.44% | 85.48% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 56.05% | -35.86% | 30.53% | -157.65% | -377.22% |